NTX-1088, a potent first-in-class, anti-PVR mAb, restores expression and function of DNAM1 for optimal DNAM1-mediated antitumor immunity Pini Tsukerman, Anas Atieh, Akram Obeidat,Keren Paz,Guy Cinamon,Tihana Lenac Rovis, Paola Kucan Brlic,Lea Hirsl,Stipan Jonjic,Ofer MandelboimMOLECULAR CANCER THERAPEUTICS（2022）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
